These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33203356)

  • 1. The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data.
    Caravagna G; Sanguinetti G; Graham TA; Sottoriva A
    BMC Bioinformatics; 2020 Nov; 21(1):531. PubMed ID: 33203356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclonal reconstruction of tumors by using machine learning and population genetics.
    Caravagna G; Heide T; Williams MJ; Zapata L; Nichol D; Chkhaidze K; Cross W; Cresswell GD; Werner B; Acar A; Chesler L; Barnes CP; Sanguinetti G; Graham TA; Sottoriva A
    Nat Genet; 2020 Sep; 52(9):898-907. PubMed ID: 32879509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data.
    Tanner G; Westhead DR; Droop A; Stead LF
    Nat Commun; 2021 Nov; 12(1):6396. PubMed ID: 34737285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MixClone: a mixture model for inferring tumor subclonal populations.
    Li Y; Xie X
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the influence of mutation detection on tumour subclonal reconstruction.
    Liu LY; Bhandari V; Salcedo A; Espiritu SMG; Morris QD; Kislinger T; Boutros PC
    Nat Commun; 2020 Dec; 11(1):6247. PubMed ID: 33288765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data.
    Malikic S; Jahn K; Kuipers J; Sahinalp SC; Beerenwinkel N
    Nat Commun; 2019 Jun; 10(1):2750. PubMed ID: 31227714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of subclonal selection in cancer from bulk sequencing data.
    Williams MJ; Werner B; Heide T; Curtis C; Barnes CP; Sottoriva A; Graham TA
    Nat Genet; 2018 Jun; 50(6):895-903. PubMed ID: 29808029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature.
    Wen Y; Wei Y; Zhang S; Li S; Liu H; Wang F; Zhao Y; Zhang D; Zhang Y
    Brief Bioinform; 2017 May; 18(3):426-440. PubMed ID: 27016391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
    Yates LR; Gerstung M; Knappskog S; Desmedt C; Gundem G; Van Loo P; Aas T; Alexandrov LB; Larsimont D; Davies H; Li Y; Ju YS; Ramakrishna M; Haugland HK; Lilleng PK; Nik-Zainal S; McLaren S; Butler A; Martin S; Glodzik D; Menzies A; Raine K; Hinton J; Jones D; Mudie LJ; Jiang B; Vincent D; Greene-Colozzi A; Adnet PY; Fatima A; Maetens M; Ignatiadis M; Stratton MR; Sotiriou C; Richardson AL; Lønning PE; Wedge DC; Campbell PJ
    Nat Med; 2015 Jul; 21(7):751-9. PubMed ID: 26099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and correct the GC bias of tumor and normal WGS data for SCNA based tumor subclonal population inferring.
    Chu Y; Teng M; Wang Y
    BMC Bioinformatics; 2018 Apr; 19(Suppl 5):112. PubMed ID: 29671389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
    Schuh A; Becq J; Humphray S; Alexa A; Burns A; Clifford R; Feller SM; Grocock R; Henderson S; Khrebtukova I; Kingsbury Z; Luo S; McBride D; Murray L; Menju T; Timbs A; Ross M; Taylor J; Bentley D
    Blood; 2012 Nov; 120(20):4191-6. PubMed ID: 22915640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.
    Deshwar AG; Vembu S; Yung CK; Jang GH; Stein L; Morris Q
    Genome Biol; 2015 Feb; 16(1):35. PubMed ID: 25786235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
    Tai AS; Peng CH; Peng SC; Hsieh WP
    PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PyClone-VI: scalable inference of clonal population structures using whole genome data.
    Gillis S; Roth A
    BMC Bioinformatics; 2020 Dec; 21(1):571. PubMed ID: 33302872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cell type-specific methylation signals in bulk whole genome bisulfite sequencing data.
    Scott CA; Duryea JD; MacKay H; Baker MS; Laritsky E; Gunasekara CJ; Coarfa C; Waterland RA
    Genome Biol; 2020 Jul; 21(1):156. PubMed ID: 32605651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing data.
    Vavoulis DV; Cutts A; Taylor JC; Schuh A
    Bioinformatics; 2021 Apr; 37(2):147-154. PubMed ID: 32722772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.
    Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Grebe SK
    J Pathol; 2008 Jun; 215(2):145-54. PubMed ID: 18393366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST.
    Chattopadhyay S; Karlsson J; Valind A; Andersson N; Gisselsson D
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34343239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine.
    Sundermann LK; Wintersinger J; Rätsch G; Stoye J; Morris Q
    PLoS Comput Biol; 2021 Jan; 17(1):e1008400. PubMed ID: 33465079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
    Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P;
    Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.